PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis. - Sandborn WJ; Mattheakis LC; Modi NB; Pugatch D; Bressler B; Lee S; Bhandari R; Kanwar B; Shames R; D'Haens G; Schreiber S; Danese S; et al. (Gastroenterology, 2021)